Explore more publications!
Vatican Health Times
Got News to Share?

Vatican Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vatican Health Times.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 3, 2025

Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer’s Disease at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025
December 3, 2025

Eisai Presents New Data on the Continued and Expanding Benefit of LEQEMBI® (lecanemab-irmb) Maintenance Treatment in Early Alzheimer’s Disease at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025

Indeterminate GlobeNewswire
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026
December 3, 2025

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026

Indeterminate GlobeNewswire
The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results of EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN
December 3, 2025

The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results of EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN

Indeterminate GlobeNewswire
Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting
December 3, 2025

Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting

Indeterminate GlobeNewswire
Mural Oncology Announces Sanction of the Scheme by the High Court
December 3, 2025

Mural Oncology Announces Sanction of the Scheme by the High Court

Indeterminate GlobeNewswire
Picard Medical, Inc. and SynCardia Systems LLC CEO to Present at CSI Focus D-HF 2025 in Frankfurt, Germany
December 3, 2025

Picard Medical, Inc. and SynCardia Systems LLC CEO to Present at CSI Focus D-HF 2025 in Frankfurt, Germany

Indeterminate GlobeNewswire
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
December 3, 2025

Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference

Indeterminate GlobeNewswire
Soleno Therapeutics Announces the Passing of Board Member William G. Harris
December 3, 2025

Soleno Therapeutics Announces the Passing of Board Member William G. Harris

Indeterminate GlobeNewswire
TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities
December 3, 2025

TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities

Indeterminate GlobeNewswire
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update
December 3, 2025

Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2025 and Provides Business Update

Indeterminate GlobeNewswire
ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Late-Breaking Oral Presentations in EGFR Atypical and EGFR exon 20 NSCLC at the ESMO Asia Congress 2025
December 3, 2025

ORIC® Pharmaceuticals Announces Enozertinib (ORIC-114) Late-Breaking Oral Presentations in EGFR Atypical and EGFR exon 20 NSCLC at the ESMO Asia Congress 2025

Indeterminate GlobeNewswire
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 3, 2025

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 3, 2025

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results
December 3, 2025

HealthEquity Reports Third Quarter Ended October 31, 2025 Financial Results

Indeterminate GlobeNewswire
Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight
December 3, 2025

Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight

Indeterminate GlobeNewswire
Neue Avextra-Kapsel verbessert Therapieerfahrung und Akzeptanz der Behandlung seitens der Patienten
December 3, 2025

Neue Avextra-Kapsel verbessert Therapieerfahrung und Akzeptanz der Behandlung seitens der Patienten

Indeterminate GlobeNewswire
Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners
December 3, 2025

Interpace Biosciences Announces Early Repayment of Debt to BroadOak Capital Partners

Indeterminate GlobeNewswire
Wake Radiology UNC Health Rex Announces the Retirement of Body Imaging Radiologist Dr. Imre Gaal Jr.
December 3, 2025

Wake Radiology UNC Health Rex Announces the Retirement of Body Imaging Radiologist Dr. Imre Gaal Jr.

Indeterminate GlobeNewswire
Nika Pharmaceuticals, Inc. (NIKA) Progress Update
December 3, 2025

Nika Pharmaceuticals, Inc. (NIKA) Progress Update

Indeterminate GlobeNewswire
Carl H. Sharperson III Joins MATTER Board of Directors
December 3, 2025

Carl H. Sharperson III Joins MATTER Board of Directors

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions